Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form 10-Q

 


 

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the quarterly period ended June 30, 2004

 

or

 

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the transition period from              to             

 

Commission File Number 0-25996

 


 

TRANSWITCH CORPORATION

(Exact name of Registrant as Specified in its Charter)

 


 

Delaware   06-1236189
(State of Incorporation)   (I.R.S. Employer Identification Number)

 

3 Enterprise Drive

Shelton, Connecticut 06484

(Address of Principal Executive Offices)

 

Telephone (203) 929-8810

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).    Yes   x    No  ¨

 

At July 30, 2004, there were 94,476,052 shares of Common Stock, par value $.001 per share, of the Registrant outstanding.

 



Table of Contents

TRANSWITCH CORPORATION AND SUBSIDIARIES

 

FORM 10-Q

 

For the Quarterly Period Ended June 30, 2004

 

Table of Contents

 

         Page

PART I.     FINANCIAL INFORMATION

    
Item 1.   Financial Statements (unaudited)     
    Consolidated Balance Sheets as of June 30, 2004 and December 31, 2003    3
    Consolidated Statements of Operations for the three and six months ended June 30, 2004 and 2003    4
    Consolidated Statements of Cash Flows for the six months ended June 30, 2004 and 2003    5
    Notes to Unaudited Consolidated Financial Statements    6
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations    15
Item 3.   Quantitative and Qualitative Disclosures about Market Risk    40
Item 4.   Controls and Procedures    41

PART II.      OTHER INFORMATION

    
Item 1.   Legal Proceedings    42
Item 2.   Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities    42
Item 4.   Submission of Vote to Shareholders    42
Item 6.   Exhibits and Reports on Form 8-K    43
    Signatures    44

 

2


Table of Contents

TRANSWITCH CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

 

    

June 30,

2004


   

December 31,

2003


 
     (unaudited)        
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 107,366     $ 142,950  

Short-term investments

     8,495       9,101  

Accounts receivable, net

     4,604       3,684  

Inventories

     3,915       2,838  

Prepaid expenses and other current assets

     3,946       2,912  
    


 


Total current assets

     128,326       161,485  

Long-term marketable securities

     39,071       27,300  

Property and equipment, net

     8,581       10,262  

Patents, net of accumulated amortization

     1,160       1,240  

Investments in non-publicly traded companies

     1,472       627  

Deferred financing costs, net

     3,618       4,462  

Other assets

     847       930  
    


 


Total assets

   $ 183,075     $ 206,306  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 2,615     $ 664  

Accrued expenses and other current liabilities

     8,335       6,728  

Accrued compensation and benefits

     2,063       1,458  

Accrued sales returns, allowances and stock rotation

     1,673       1,671  

Accrued interest

     1,587       1,665  

Restructuring liabilities

     968       1,454  
    


 


Total current liabilities

     17,241       13,640  

Restructuring liabilities – long-term

     22,201       22,689  

5.45% Convertible Plus Cash NotesSM due 2007, net of debt discount of $17,758 and $21,742, respectively

     74,261       75,866  

4.50% Convertible Notes due 2005

     24,442       24,442  

Derivative liability

     12,934       20,659  
    


 


Total liabilities

     151,079       157,296  
    


 


Commitments and contingencies

                

Stockholders’ equity:

                

Common stock, $.001 par value; 300,000,000 shares authorized; 94,396,613 and 90,953,205 shares issued and outstanding at June 30, 2004 and December 31, 2003, respectively

     94       91  

Additional paid-in capital

     296,834       291,115  

Accumulated other comprehensive income

     695       994  

Accumulated deficit

     (265,627 )     (243,190 )
    


 


Total stockholders’ equity

     31,996       49,010  
    


 


Total liabilities and stockholders’ equity

   $ 183,075     $ 206,306  
    


 


 

See accompanying notes to unaudited consolidated financial statements.

 

3


Table of Contents

TRANSWITCH CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

     Three Months Ended
June 30,


   

Six Months Ended

June 30,


 
     2004

    2003

    2004

    2003

 

Net revenues:

                                

Product revenues

   $ 8,501     $ 6,516     $ 16,704     $ 10,447  

Service revenues

     186       91       188       258  
    


 


 


 


Total net revenues

     8,687       6,607       16,892       10,705  

Cost of revenues:

                                

Cost of product revenues

     2,246       1,759       4,392       2,997  

Provision for excess inventories

     —         1,498       —         1,498  

Cost of service revenues

     158       13       158       115  
    


 


 


 


Total cost of revenues

     2,404       3,270       4,550       4,610  
    


 


 


 


Gross profit

     6,283       3,337       12,342       6,095  

Operating expenses:

                                

Research and development

     11,972       10,468       25,641       20,698  

Marketing and sales

     3,212       2,710       6,543       5,392  

General and administrative

     1,792       1,248       3,663       2,720  

Restructuring (benefit) charge and asset impairments, net

     (61 )     138       (212 )     3,925  
    


 


 


 


Total operating expenses

     16,915       14,564       35,635       32,735  
    


 


 


 


Operating loss

     (10,632 )     (11,227 )     (23,293 )     (26,640 )

Other income (expense):

                                

Impairment of investments in non-publicly traded companies

     (12 )     —         (123 )     (50 )

Equity in net losses of affiliates

     —         (471 )     —         (786 )

Change in fair value of derivative liability

     6,951       —         7,726       —    

Loss on extinguishment of debt

     (1,241 )     —         (1,241 )     —    

Other income

     378       —         378       —    

Interest (expense) income:

                                

Interest income

     599       738       1,131       1,585  

Interest expense

     (3,146 )     (1,486 )     (6,565 )     (3,038 )
    


 


 


 


Interest expense, net

     (2,547 )     (748 )     (5,434 )     (1,453 )
    


 


 


 


Total other income (expense), net

     3,529       (1,219 )     1,306       (2,289 )
    


 


 


 


Loss before income taxes, extraordinary loss and cumulative effect of adoption of and changes in accounting principles

     (7,103 )     (12,446 )     (21,987 )     (28,929 )

Income tax expense

     70       115       173       184  
    


 


 


 


Loss before extraordinary loss and cumulative effect of adoption of and changes in accounting principles

     (7,173 )     (12,561 )     (22,160 )     (29,113 )

Extraordinary loss upon consolidation of TeraOp (USA), Inc.

     —         —         —         (83 )

Cumulative effect on prior years of adoption of and retroactive application of FIN 46R and new depreciation method

     —         —         (277 )     (805 )
    


 


 


 


Net loss

   $ (7,173 )   $ (12,561 )   $ (22,437 )   $ (30,001 )
    


 


 


 


Basic and diluted loss per common share:

                                

Loss before extraordinary loss and cumulative effect of adoption of and changes in accounting principles

   $ (0.08 )   $ (0.14 )   $ (0.24 )   $ (0.32 )

Extraordinary loss upon consolidation of TeraOp (USA), Inc.

     —         —         —         —    

Cumulative effect on prior years of adoption of and retroactive application of FIN 46R and new depreciation method

     —         —         —         (0.01 )
    


 


 


 


Net loss

   $ (0.08 )   $ (0.14 )   $ (0.24 )   $ (0.33 )
    


 


 


 


Basic and diluted average common shares outstanding

     92,587       90,167       91,809       90,166  

 

See accompanying notes to unaudited consolidated financial statements.

 

4


Table of Contents

TRANSWITCH CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)